Last updated 2026-07-23
- Acquired by Adicet Bio, Jan 2016
- Raised $4M Series A led by Pontifax, Mar 2010
- Raised $400k grant, Jun 2008
Total raised
$4.4M
Last: Undisclosed Round 2010-04
Stage
Acquired
Founded
2006
Headcount
1-10
HQ
Haifa, Israel
Sector
Health Tech & Life Sciences
About
Applied Immune Technologies (AIT) is a drug development company based in Haifa, Israel, specializing in T-cell-receptor-like (TCRL) antibodies for therapeutic and diagnostic applications in a variety of cancer, viral, and autoimmune diseases. The company also focuses on the identification and validation of novel therapeutic targets. AIT's core technology platforms encompass the identification and validation of novel MHC-based targets, as well as the development of therapeutic human recombinant TCRL antibodies. AIT also established Epitarget™, a proprietary technology to identify and validate novel disease-specific peptide targets.
Funding history · 2 rounds · $4.4M total
2010-03
A Round
$4.0M
★ Pontifax
2008-06
Grant
$400K
Headcount over time
From 126 (2018-06) to 2 (2024-08) · -124 (-98%) · 2 points · source: Finder history + radar grounding
Q&A
- What is Applied Immune Technologies' primary focus?
- Applied Immune Technologies (AIT) is a drug development company specializing in T-cell-receptor-like (TCRL) antibodies for therapeutic and diagnostic applications in various cancer, viral, and autoimmune diseases. The company also focuses on identifying and validating novel therapeutic targets.
- When was Applied Immune Technologies founded?
- Applied Immune Technologies was founded in February 2006.
- What is the current status of Applied Immune Technologies?
- Applied Immune Technologies was acquired by Adicet Bio in January 2016 and is currently inactive.
- How much funding has Applied Immune Technologies raised in total?
- Applied Immune Technologies has raised a total of $4,400,000.
- Which investors participated in Applied Immune Technologies' funding rounds?
- Applied Immune Technologies received funding from the Office of the Chief Scientist and Pontifax.
- What is the employee count for Applied Immune Technologies?
- Applied Immune Technologies has 1-10 employees.
- Who is a founder of Applied Immune Technologies?
- Aya Yakobovitz, Ph.D. is a founder, director, and senior strategic advisor at Applied Immune Technologies.
Team · 2
Prof. Yoram Reiter
Founder · Founder
Mira Peled-Kamar
Founder · Chief Executive Officer
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
viral-diseasescancerantibodiesbiotechnologybiopharmaceuticaltherapeuticsdiagnosticsautoimmune-diseasespatientsdoctors
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | tcrl.co.il |
|---|---|
| linkedin.com/company/6951128 |
Identifiers & details
| Legal name | Applied Immune Technologies Ltd. |
|---|---|
| Founded | 2006-2 |
| Status reason | Acquired (Inactive) by Adicet Bio on Jan 2016 - closed due to acquisition |
Acquisitions & public offerings
Acquired by Adicet Bio 2016-01
Radar intelligence
Patents
| EPO | 22 |
|---|
Web history (Wayback)
| Domain | tcrl.co.il |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 513800649 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2006-02-21 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 3 — other (1), violation (1), annual_report (1) |
| Registered address | אידר 15 חיפה |
Recent registry events
| Date | Event |
|---|---|
| 2026-02-18 | עדכון כתובת ו/או מען דיגיטלי |
| 2026-06-12 | עדכון הפרה |
| 2026-06-10 | דו~ח שנתי |